Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day
R(+) pramipexole dihydrochloride monohydrate [R(+)PPX], an experimental neuroprotective drug, is provided in this open label extension study to ALS patients who have participated in earlier clinical protocols.
Amyotrophic Lateral Sclerosis
Drug: R(+) pramipexole dihydrochloride monohydrate
|Study Type:||Expanded Access What is Expanded Access?|
|Official Title:||Open Label Extension for Treating ALS With R(+) Pramipexole at 60 Milligrams Per Day|
No Contacts or Locations Provided